Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer.
Xing GaoOsbert Qi-Yao LeowChien-Hung ChiuMing-Mo HouJason Chia-Hsun HsiehYin Kai ChaoPublished in: Journal of personalized medicine (2022)
CTCs count assessed in combination with CRE can potentially help identify patients with EC who achieved MaHR after nCRT.